Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Biothrax (Anthrax Vaccine) Market Growth 2022-2028

  • LP 4857533
  • 123 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Biothrax (Anthrax Vaccine) will have significant change from previous year. According to our (LP Information) latest study, the global Biothrax (Anthrax Vaccine) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Biothrax (Anthrax Vaccine) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Biothrax (Anthrax Vaccine) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biothrax (Anthrax Vaccine) market, reaching US$ million by the year 2028. As for the Europe Biothrax (Anthrax Vaccine) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Biothrax (Anthrax Vaccine) players cover Merial, Merck, Zoetis, and Bayer Sanidad Animal, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Biothrax (Anthrax Vaccine) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Live Vaccines

Cell Free PA Vaccines

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Human Use

Animal Use

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merial

Merck

Zoetis

Bayer Sanidad Animal

Colorado Serum

PharmAthene

Tiankang

Biogénesis-Bago

CAVAC

Rosenbusch

Agrovet

Vecol

CVCRI

IVPM

Prondil

CDV

Indian Immunologicals

Botswana Vaccine Institute

Ceva Santé Animale

Intervac

JOVAC

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biothrax (Anthrax Vaccine) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Biothrax (Anthrax Vaccine) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Biothrax (Anthrax Vaccine) by Country/Region, 2017, 2022 & 2028

2.2 Biothrax (Anthrax Vaccine) Segment by Type

2.2.1 Live Vaccines

2.2.2 Cell Free PA Vaccines

2.3 Biothrax (Anthrax Vaccine) Sales by Type

2.3.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2017-2022)

2.3.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Biothrax (Anthrax Vaccine) Sale Price by Type (2017-2022)

2.4 Biothrax (Anthrax Vaccine) Segment by Application

2.4.1 Human Use

2.4.2 Animal Use

2.5 Biothrax (Anthrax Vaccine) Sales by Application

2.5.1 Global Biothrax (Anthrax Vaccine) Sale Market Share by Application (2017-2022)

2.5.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Biothrax (Anthrax Vaccine) Sale Price by Application (2017-2022)

3 Global Biothrax (Anthrax Vaccine) by Company

3.1 Global Biothrax (Anthrax Vaccine) Breakdown Data by Company

3.1.1 Global Biothrax (Anthrax Vaccine) Annual Sales by Company (2020-2022)

3.1.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Company (2020-2022)

3.2 Global Biothrax (Anthrax Vaccine) Annual Revenue by Company (2020-2022)

3.2.1 Global Biothrax (Anthrax Vaccine) Revenue by Company (2020-2022)

3.2.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company (2020-2022)

3.3 Global Biothrax (Anthrax Vaccine) Sale Price by Company

3.4 Key Manufacturers Biothrax (Anthrax Vaccine) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Biothrax (Anthrax Vaccine) Product Location Distribution

3.4.2 Players Biothrax (Anthrax Vaccine) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Biothrax (Anthrax Vaccine) by Geographic Region

4.1 World Historic Biothrax (Anthrax Vaccine) Market Size by Geographic Region (2017-2022)

4.1.1 Global Biothrax (Anthrax Vaccine) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Biothrax (Anthrax Vaccine) Annual Revenue by Geographic Region

4.2 World Historic Biothrax (Anthrax Vaccine) Market Size by Country/Region (2017-2022)

4.2.1 Global Biothrax (Anthrax Vaccine) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Biothrax (Anthrax Vaccine) Annual Revenue by Country/Region

4.3 Americas Biothrax (Anthrax Vaccine) Sales Growth

4.4 APAC Biothrax (Anthrax Vaccine) Sales Growth

4.5 Europe Biothrax (Anthrax Vaccine) Sales Growth

4.6 Middle East & Africa Biothrax (Anthrax Vaccine) Sales Growth

5 Americas

5.1 Americas Biothrax (Anthrax Vaccine) Sales by Country

5.1.1 Americas Biothrax (Anthrax Vaccine) Sales by Country (2017-2022)

5.1.2 Americas Biothrax (Anthrax Vaccine) Revenue by Country (2017-2022)

5.2 Americas Biothrax (Anthrax Vaccine) Sales by Type

5.3 Americas Biothrax (Anthrax Vaccine) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biothrax (Anthrax Vaccine) Sales by Region

6.1.1 APAC Biothrax (Anthrax Vaccine) Sales by Region (2017-2022)

6.1.2 APAC Biothrax (Anthrax Vaccine) Revenue by Region (2017-2022)

6.2 APAC Biothrax (Anthrax Vaccine) Sales by Type

6.3 APAC Biothrax (Anthrax Vaccine) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Biothrax (Anthrax Vaccine) by Country

7.1.1 Europe Biothrax (Anthrax Vaccine) Sales by Country (2017-2022)

7.1.2 Europe Biothrax (Anthrax Vaccine) Revenue by Country (2017-2022)

7.2 Europe Biothrax (Anthrax Vaccine) Sales by Type

7.3 Europe Biothrax (Anthrax Vaccine) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biothrax (Anthrax Vaccine) by Country

8.1.1 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2017-2022)

8.2 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Type

8.3 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Biothrax (Anthrax Vaccine)

10.3 Manufacturing Process Analysis of Biothrax (Anthrax Vaccine)

10.4 Industry Chain Structure of Biothrax (Anthrax Vaccine)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Biothrax (Anthrax Vaccine) Distributors

11.3 Biothrax (Anthrax Vaccine) Customer

12 World Forecast Review for Biothrax (Anthrax Vaccine) by Geographic Region

12.1 Global Biothrax (Anthrax Vaccine) Market Size Forecast by Region

12.1.1 Global Biothrax (Anthrax Vaccine) Forecast by Region (2023-2028)

12.1.2 Global Biothrax (Anthrax Vaccine) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Biothrax (Anthrax Vaccine) Forecast by Type

12.7 Global Biothrax (Anthrax Vaccine) Forecast by Application

13 Key Players Analysis

13.1 Merial

13.1.1 Merial Company Information

13.1.2 Merial Biothrax (Anthrax Vaccine) Product Offered

13.1.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merial Main Business Overview

13.1.5 Merial Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Biothrax (Anthrax Vaccine) Product Offered

13.2.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Zoetis

13.3.1 Zoetis Company Information

13.3.2 Zoetis Biothrax (Anthrax Vaccine) Product Offered

13.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Zoetis Main Business Overview

13.3.5 Zoetis Latest Developments

13.4 Bayer Sanidad Animal

13.4.1 Bayer Sanidad Animal Company Information

13.4.2 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Offered

13.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bayer Sanidad Animal Main Business Overview

13.4.5 Bayer Sanidad Animal Latest Developments

13.5 Colorado Serum

13.5.1 Colorado Serum Company Information

13.5.2 Colorado Serum Biothrax (Anthrax Vaccine) Product Offered

13.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Colorado Serum Main Business Overview

13.5.5 Colorado Serum Latest Developments

13.6 PharmAthene

13.6.1 PharmAthene Company Information

13.6.2 PharmAthene Biothrax (Anthrax Vaccine) Product Offered

13.6.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 PharmAthene Main Business Overview

13.6.5 PharmAthene Latest Developments

13.7 Tiankang

13.7.1 Tiankang Company Information

13.7.2 Tiankang Biothrax (Anthrax Vaccine) Product Offered

13.7.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Tiankang Main Business Overview

13.7.5 Tiankang Latest Developments

13.8 Biogénesis-Bago

13.8.1 Biogénesis-Bago Company Information

13.8.2 Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Offered

13.8.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Biogénesis-Bago Main Business Overview

13.8.5 Biogénesis-Bago Latest Developments

13.9 CAVAC

13.9.1 CAVAC Company Information

13.9.2 CAVAC Biothrax (Anthrax Vaccine) Product Offered

13.9.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 CAVAC Main Business Overview

13.9.5 CAVAC Latest Developments

13.10 Rosenbusch

13.10.1 Rosenbusch Company Information

13.10.2 Rosenbusch Biothrax (Anthrax Vaccine) Product Offered

13.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Rosenbusch Main Business Overview

13.10.5 Rosenbusch Latest Developments

13.11 Agrovet

13.11.1 Agrovet Company Information

13.11.2 Agrovet Biothrax (Anthrax Vaccine) Product Offered

13.11.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Agrovet Main Business Overview

13.11.5 Agrovet Latest Developments

13.12 Vecol

13.12.1 Vecol Company Information

13.12.2 Vecol Biothrax (Anthrax Vaccine) Product Offered

13.12.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Vecol Main Business Overview

13.12.5 Vecol Latest Developments

13.13 CVCRI

13.13.1 CVCRI Company Information

13.13.2 CVCRI Biothrax (Anthrax Vaccine) Product Offered

13.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 CVCRI Main Business Overview

13.13.5 CVCRI Latest Developments

13.14 IVPM

13.14.1 IVPM Company Information

13.14.2 IVPM Biothrax (Anthrax Vaccine) Product Offered

13.14.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 IVPM Main Business Overview

13.14.5 IVPM Latest Developments

13.15 Prondil

13.15.1 Prondil Company Information

13.15.2 Prondil Biothrax (Anthrax Vaccine) Product Offered

13.15.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Prondil Main Business Overview

13.15.5 Prondil Latest Developments

13.16 CDV

13.16.1 CDV Company Information

13.16.2 CDV Biothrax (Anthrax Vaccine) Product Offered

13.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 CDV Main Business Overview

13.16.5 CDV Latest Developments

13.17 Indian Immunologicals

13.17.1 Indian Immunologicals Company Information

13.17.2 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Offered

13.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Indian Immunologicals Main Business Overview

13.17.5 Indian Immunologicals Latest Developments

13.18 Botswana Vaccine Institute

13.18.1 Botswana Vaccine Institute Company Information

13.18.2 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Offered

13.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Botswana Vaccine Institute Main Business Overview

13.18.5 Botswana Vaccine Institute Latest Developments

13.19 Ceva Santé Animale

13.19.1 Ceva Santé Animale Company Information

13.19.2 Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Offered

13.19.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Ceva Santé Animale Main Business Overview

13.19.5 Ceva Santé Animale Latest Developments

13.20 Intervac

13.20.1 Intervac Company Information

13.20.2 Intervac Biothrax (Anthrax Vaccine) Product Offered

13.20.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Intervac Main Business Overview

13.20.5 Intervac Latest Developments

13.21 JOVAC

13.21.1 JOVAC Company Information

13.21.2 JOVAC Biothrax (Anthrax Vaccine) Product Offered

13.21.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 JOVAC Main Business Overview

13.21.5 JOVAC Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Biothrax (Anthrax Vaccine) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Biothrax (Anthrax Vaccine) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live Vaccines

Table 4. Major Players of Cell Free PA Vaccines

Table 5. Global Biothrax (Anthrax Vaccine) Sales by Type (2017-2022) & (K Units)

Table 6. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2017-2022)

Table 7. Global Biothrax (Anthrax Vaccine) Revenue by Type (2017-2022) & ($ million)

Table 8. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2017-2022)

Table 9. Global Biothrax (Anthrax Vaccine) Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Biothrax (Anthrax Vaccine) Sales by Application (2017-2022) & (K Units)

Table 11. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2017-2022)

Table 12. Global Biothrax (Anthrax Vaccine) Revenue by Application (2017-2022)

Table 13. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2017-2022)

Table 14. Global Biothrax (Anthrax Vaccine) Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Biothrax (Anthrax Vaccine) Sales by Company (2020-2022) & (K Units)

Table 16. Global Biothrax (Anthrax Vaccine) Sales Market Share by Company (2020-2022)

Table 17. Global Biothrax (Anthrax Vaccine) Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company (2020-2022)

Table 19. Global Biothrax (Anthrax Vaccine) Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Biothrax (Anthrax Vaccine) Producing Area Distribution and Sales Area

Table 21. Players Biothrax (Anthrax Vaccine) Products Offered

Table 22. Biothrax (Anthrax Vaccine) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Biothrax (Anthrax Vaccine) Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Biothrax (Anthrax Vaccine) Sales Market Share Geographic Region (2017-2022)

Table 27. Global Biothrax (Anthrax Vaccine) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Biothrax (Anthrax Vaccine) Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Biothrax (Anthrax Vaccine) Sales Market Share by Country/Region (2017-2022)

Table 31. Global Biothrax (Anthrax Vaccine) Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Biothrax (Anthrax Vaccine) Sales by Country (2017-2022) & (K Units)

Table 34. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Country (2017-2022)

Table 35. Americas Biothrax (Anthrax Vaccine) Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2017-2022)

Table 37. Americas Biothrax (Anthrax Vaccine) Sales by Type (2017-2022) & (K Units)

Table 38. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Type (2017-2022)

Table 39. Americas Biothrax (Anthrax Vaccine) Sales by Application (2017-2022) & (K Units)

Table 40. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Application (2017-2022)

Table 41. APAC Biothrax (Anthrax Vaccine) Sales by Region (2017-2022) & (K Units)

Table 42. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Region (2017-2022)

Table 43. APAC Biothrax (Anthrax Vaccine) Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2017-2022)

Table 45. APAC Biothrax (Anthrax Vaccine) Sales by Type (2017-2022) & (K Units)

Table 46. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Type (2017-2022)

Table 47. APAC Biothrax (Anthrax Vaccine) Sales by Application (2017-2022) & (K Units)

Table 48. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Application (2017-2022)

Table 49. Europe Biothrax (Anthrax Vaccine) Sales by Country (2017-2022) & (K Units)

Table 50. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country (2017-2022)

Table 51. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2017-2022)

Table 53. Europe Biothrax (Anthrax Vaccine) Sales by Type (2017-2022) & (K Units)

Table 54. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Type (2017-2022)

Table 55. Europe Biothrax (Anthrax Vaccine) Sales by Application (2017-2022) & (K Units)

Table 56. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Biothrax (Anthrax Vaccine)

Table 66. Key Market Challenges & Risks of Biothrax (Anthrax Vaccine)

Table 67. Key Industry Trends of Biothrax (Anthrax Vaccine)

Table 68. Biothrax (Anthrax Vaccine) Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Biothrax (Anthrax Vaccine) Distributors List

Table 71. Biothrax (Anthrax Vaccine) Customer List

Table 72. Global Biothrax (Anthrax Vaccine) Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Biothrax (Anthrax Vaccine) Sales Market Forecast by Region

Table 74. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Biothrax (Anthrax Vaccine) Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Biothrax (Anthrax Vaccine) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Biothrax (Anthrax Vaccine) Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Biothrax (Anthrax Vaccine) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Biothrax (Anthrax Vaccine) Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Biothrax (Anthrax Vaccine) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Biothrax (Anthrax Vaccine) Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Biothrax (Anthrax Vaccine) Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merial Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 93. Merial Biothrax (Anthrax Vaccine) Product Offered

Table 94. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Merial Main Business

Table 96. Merial Latest Developments

Table 97. Merck Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck Biothrax (Anthrax Vaccine) Product Offered

Table 99. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Merck Main Business

Table 101. Merck Latest Developments

Table 102. Zoetis Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 103. Zoetis Biothrax (Anthrax Vaccine) Product Offered

Table 104. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Zoetis Main Business

Table 106. Zoetis Latest Developments

Table 107. Bayer Sanidad Animal Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 108. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Offered

Table 109. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Bayer Sanidad Animal Main Business

Table 111. Bayer Sanidad Animal Latest Developments

Table 112. Colorado Serum Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 113. Colorado Serum Biothrax (Anthrax Vaccine) Product Offered

Table 114. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Colorado Serum Main Business

Table 116. Colorado Serum Latest Developments

Table 117. PharmAthene Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 118. PharmAthene Biothrax (Anthrax Vaccine) Product Offered

Table 119. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. PharmAthene Main Business

Table 121. PharmAthene Latest Developments

Table 122. Tiankang Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 123. Tiankang Biothrax (Anthrax Vaccine) Product Offered

Table 124. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Tiankang Main Business

Table 126. Tiankang Latest Developments

Table 127. Biogénesis-Bago Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 128. Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Offered

Table 129. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Biogénesis-Bago Main Business

Table 131. Biogénesis-Bago Latest Developments

Table 132. CAVAC Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 133. CAVAC Biothrax (Anthrax Vaccine) Product Offered

Table 134. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. CAVAC Main Business

Table 136. CAVAC Latest Developments

Table 137. Rosenbusch Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 138. Rosenbusch Biothrax (Anthrax Vaccine) Product Offered

Table 139. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Rosenbusch Main Business

Table 141. Rosenbusch Latest Developments

Table 142. Agrovet Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 143. Agrovet Biothrax (Anthrax Vaccine) Product Offered

Table 144. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Agrovet Main Business

Table 146. Agrovet Latest Developments

Table 147. Vecol Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 148. Vecol Biothrax (Anthrax Vaccine) Product Offered

Table 149. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Vecol Main Business

Table 151. Vecol Latest Developments

Table 152. CVCRI Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 153. CVCRI Biothrax (Anthrax Vaccine) Product Offered

Table 154. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. CVCRI Main Business

Table 156. CVCRI Latest Developments

Table 157. IVPM Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 158. IVPM Biothrax (Anthrax Vaccine) Product Offered

Table 159. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. IVPM Main Business

Table 161. IVPM Latest Developments

Table 162. Prondil Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 163. Prondil Biothrax (Anthrax Vaccine) Product Offered

Table 164. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. Prondil Main Business

Table 166. Prondil Latest Developments

Table 167. CDV Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 168. CDV Biothrax (Anthrax Vaccine) Product Offered

Table 169. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 170. CDV Main Business

Table 171. CDV Latest Developments

Table 172. Indian Immunologicals Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 173. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Offered

Table 174. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 175. Indian Immunologicals Main Business

Table 176. Indian Immunologicals Latest Developments

Table 177. Botswana Vaccine Institute Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 178. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Offered

Table 179. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 180. Botswana Vaccine Institute Main Business

Table 181. Botswana Vaccine Institute Latest Developments

Table 182. Ceva Santé Animale Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 183. Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Offered

Table 184. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 185. Ceva Santé Animale Main Business

Table 186. Ceva Santé Animale Latest Developments

Table 187. Intervac Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 188. Intervac Biothrax (Anthrax Vaccine) Product Offered

Table 189. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 190. Intervac Main Business

Table 191. Intervac Latest Developments

Table 192. JOVAC Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors

Table 193. JOVAC Biothrax (Anthrax Vaccine) Product Offered

Table 194. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 195. JOVAC Main Business

Table 196. JOVAC Latest Developments

List of Figures

Figure 1. Picture of Biothrax (Anthrax Vaccine)

Figure 2. Biothrax (Anthrax Vaccine) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Biothrax (Anthrax Vaccine) Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Biothrax (Anthrax Vaccine) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Biothrax (Anthrax Vaccine) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live Vaccines

Figure 10. Product Picture of Cell Free PA Vaccines

Figure 11. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type in 2021

Figure 12. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2017-2022)

Figure 13. Biothrax (Anthrax Vaccine) Consumed in Human Use

Figure 14. Global Biothrax (Anthrax Vaccine) Market: Human Use (2017-2022) & (K Units)

Figure 15. Biothrax (Anthrax Vaccine) Consumed in Animal Use

Figure 16. Global Biothrax (Anthrax Vaccine) Market: Animal Use (2017-2022) & (K Units)

Figure 17. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2017-2022)

Figure 18. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application in 2021

Figure 19. Biothrax (Anthrax Vaccine) Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company in 2021

Figure 21. Global Biothrax (Anthrax Vaccine) Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Geographic Region in 2021

Figure 23. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2017-2022)

Figure 24. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Country/Region in 2021

Figure 25. Americas Biothrax (Anthrax Vaccine) Sales 2017-2022 (K Units)

Figure 26. Americas Biothrax (Anthrax Vaccine) Revenue 2017-2022 ($ Millions)

Figure 27. APAC Biothrax (Anthrax Vaccine) Sales 2017-2022 (K Units)

Figure 28. APAC Biothrax (Anthrax Vaccine) Revenue 2017-2022 ($ Millions)

Figure 29. Europe Biothrax (Anthrax Vaccine) Sales 2017-2022 (K Units)

Figure 30. Europe Biothrax (Anthrax Vaccine) Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Biothrax (Anthrax Vaccine) Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue 2017-2022 ($ Millions)

Figure 33. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2021

Figure 34. Americas Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2021

Figure 35. United States Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2021

Figure 40. APAC Biothrax (Anthrax Vaccine) Revenue Market Share by Regions in 2021

Figure 41. China Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2021

Figure 48. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2021

Figure 49. Germany Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2021

Figure 56. Egypt Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Biothrax (Anthrax Vaccine) in 2021

Figure 62. Manufacturing Process Analysis of Biothrax (Anthrax Vaccine)

Figure 63. Industry Chain Structure of Biothrax (Anthrax Vaccine)

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390